1. Home
  2. LYEL vs OVBC Comparison

LYEL vs OVBC Comparison

Compare LYEL & OVBC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Lyell Immunopharma Inc.

LYEL

Lyell Immunopharma Inc.

SELL

Current Price

$13.64

Market Cap

195.8M

Sector

Health Care

ML Signal

SELL

Logo Ohio Valley Banc Corp.

OVBC

Ohio Valley Banc Corp.

SELL

Current Price

$45.42

Market Cap

220.0M

Sector

Finance

ML Signal

SELL

Company Overview

Basic Information
Metric
LYEL
OVBC
Founded
2018
1872
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
195.8M
220.0M
IPO Year
2021
1996

Fundamental Metrics

Financial Performance
Metric
LYEL
OVBC
Price
$13.64
$45.42
Analyst Decision
Buy
Analyst Count
8
0
Target Price
★ $37.63
N/A
AVG Volume (30 Days)
★ 212.6K
15.1K
Earning Date
11-04-2026
10-27-2026
Dividend Yield
N/A
★ 2.20%
EPS Growth
N/A
★ 42.67
EPS
N/A
★ 2.23
Revenue
★ $36,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
★ N/A
$20.36
Revenue Growth
N/A
★ N/A
52 Week Low
$7.20
$36.75
52 Week High
$45.00
$51.25

Technical Indicators

Market Signals
Indicator
LYEL
OVBC
Relative Strength Index (RSI) 54.63 36.61
Support Level $12.25 $44.53
Resistance Level $14.97 $44.84
Average True Range (ATR) 1.67 1.40
MACD -0.18 -0.52
Stochastic Oscillator 43.74 22.96

Price Performance

Historical Comparison
LYEL
OVBC

About LYEL Lyell Immunopharma Inc.

Lyell Immunopharma Inc s a late-stage clinical cell therapy company advancing a pipeline of proprietary next-generation autologous chimeric antigen receptor (CAR) T-cell product candidates for patients with hematologic malignancies and solid tumors. The Company's product candidate, rondecabtagene autoleucel (ronde-cel, also known as LYL314), is an autologous dual-targeting CD19/CD20 CAR T-cell therapy in development for large B-cell lymphoma (LBCL). The Company has recently acquired exclusive rights outside of mainland China, Hong Kong, Macau and Taiwan, to a novel guanylyl cyclase C (GCC)-targeted CAR T-cell product candidate in early clinical development for refractory metastatic colorectal cancer (mCRC) and other GCC-expressing cancers.

About OVBC Ohio Valley Banc Corp.

Ohio Valley Banc Corporation is a financial holding company. The bank is a full-service financial institution offering a blend of commercial and consumer banking services in Southeastern Ohio and western West Virginia. The banking services offered by the bank include the acceptance of deposits in checking, savings, time and money market accounts; the making and servicing of personal, commercial, and student loans; and the making of construction and real estate loans. It also offers individual retirement accounts, safe deposit boxes, wire transfers, and other standard banking products and services.

Share on Social Networks: